Investigation of the Effectiveness of Structured Education According to Premenstrual Syndrome Symptom Map
The Effectiveness of Structured Training According to the Premenstrual Syndrome Symptom Map
1 other identifier
interventional
101
1 country
1
Brief Summary
In this study, it was aimed to evaluate the effectiveness of the training structured according to the PMS symptom map. This experimental (randomised-controlled) study was conducted with women of reproductive age with PMS. Women who met the inclusion criteria and volunteered to participate in the study constituted the sample of the study. As a result of block randomisation, 55 women were assigned to the intervention group and 55 women to the control group. Pre-test data were collected from the women allocated to the intervention and control groups by means of data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, Premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale). The intervention group received a 3-session structured training according to the PMS symptom map, while the control group did not receive any intervention. Women in the intervention group completed the post-test data on the last day of the 2nd cycle after the training, while women in the control group completed the post-test data on the last day of the 2nd cycle after the pre-test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 5, 2024
CompletedFirst Submitted
Initial submission to the registry
September 3, 2024
CompletedFirst Posted
Study publicly available on registry
September 5, 2024
CompletedSeptember 5, 2024
September 1, 2024
7 months
September 3, 2024
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Premenstrual syndrome assessment scale
a scale used to measure the degree of premenstrual syndrome
pre-intervention, 2 month after intervention
premenstrual syndrome specific life satisfaction scale
Premenstrual syndrome specific life satisfaction scale evaluates life satisfaction of women with PMS
pre-intervention, 2 month after intervention
DAS depression stress anxiety assessment scale
DAS depression stress anxiety assessment scale, evaluates psychological symptoms
pre-intervention, 2 month after intervention
VAS pain score
1.421 / 5.000 VAS pain score measures pain score
pre-intervention, 2 month after intervention
Study Arms (2)
Experimental group
EXPERIMENTALThe intervention group received a 3-session PMS symptom map-structured training by the responsible and first author (ADK). Before the training, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety assessment scale, premenstrual syndrome assessment scale and premenstrual syndrome-specific life satisfaction scale). After the training, post-test data were collected on the last day of the 1nd cycle.
Control group
NO INTERVENTIONNo intervention was applied to the control group. After the participants were divided into groups by randomization, pre-test data were collected using data collection tools (VAS pain scoring, DAS depression stress anxiety rating scale, premenstrual syndrome rating scale and premenstrual syndrome specific life satisfaction scale). After the pre-test, post-test data were collected on the last day of the cycle after 1 menstrual cycles.
Interventions
A symptom map consisting of evidence-based practices for coping with PMS symptoms was created. An educational content based on this map was prepared and applied to women with PMS to evaluate whether it was effective compared to the control group.
Eligibility Criteria
You may qualify if:
- Meeting ACOG's PMS diagnostic criteria Being over 18 years of age, Not using psychotherapeutic medications, Not having a mental illness, Not being pregnant, Agreeing to participate in the study
You may not qualify if:
- Not having regular menstruation in the last 3 months, Using analgesics during menstruation while participating in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sakarya University
Sakarya, 54050, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2024
First Posted
September 5, 2024
Study Start
November 1, 2023
Primary Completion
June 10, 2024
Study Completion
August 5, 2024
Last Updated
September 5, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share